How to use AlphaBind Antibody-Antigen Affinity Prediction Online

Rank antibody candidates with pretrained AlphaBind or optional target-specific fine-tuning.

AlphaBind is a sequence-based antibody-antigen affinity model designed for guided antibody optimization. It combines residue embeddings from NVIDIA's ESM-2nv 3B protein language model with a transformer affinity regressor pretrained on approximately 7.5 million quantitative antibody-antigen measurements.

On Neurosnap, researchers submit one or more Antibody Candidates and one shared Antigen Sequence. With no dataset, the service runs the public pretrained checkpoint directly. Researchers can optionally upload measured antibody-antigen pairs to fine-tune that checkpoint before ranking related candidates against the same antigen. Published evaluation found inconsistent zero-shot correlations across evaluated antibody families, so pretrained-only results should be treated as comparative screening estimates rather than calibrated experimental affinities.

How AlphaBind Antibody-Antigen Affinity Prediction Works

To use the pretrained base model, leave Fine-Tuning Dataset blank. AlphaBind then reports scores on its native log10(KD nM) scale, where lower values indicate stronger predicted binding, together with a nanomolar conversion. Use these results to compare related candidates and confirm promising designs with orthogonal modeling or experiments.

For target-specific adaptation, provide a CSV with the case-sensitive columns sequence_a, sequence_alpha, and Kd. Each row must contain one unique antibody-antigen pair, every sequence_alpha must exactly match the submitted Antigen Sequence, and at least ten measured rows are required. Set Training Target Scale to log10(KD nM) only for log10-transformed dissociation constants in nanomolar units. Use Custom Lower-Is-Better Score for enrichment or another proxy assay.

With a CSV, Neurosnap computes ESM-2nv embeddings, fine-tunes the checkpoint, selects the checkpoint with the best validation loss, and returns training metrics and the fine-tuned model alongside predictions. Without a CSV, those training steps and artifacts are skipped. Each antibody-antigen pair is limited to 600 total residues, and all predictions should be checked with held-out experimental data before design decisions.

What is Neurosnap?

Neurosnap is the leading platform for bioinformatics and computational science focused on expanding access to powerful modeling and simulation tools. Because many state-of-the-art machine learning systems remain complex to install, configure, and scale, Neurosnap offers a clean, browser-based workspace that removes the burden of infrastructure management, dependency conflicts, and command-line tooling.

Built for biologists, chemists, and cross-disciplinary scientists, the platform enables advanced computational workflows without requiring expertise in software engineering or cloud architecture. Researchers can launch analyses through an intuitive interface, connect programmatically through a comprehensive API, and rely on automated resource management to scale workloads efficiently. By taking care of the underlying compute and operational complexity, Neurosnap allows teams to devote their energy to scientific progress and faster iteration. Security and data protection remain foundational principles, with clear safeguards outlined in our Terms of Use and Privacy Policy to ensure your work stays protected.

Advancing Discovery with AlphaBind Antibody-Antigen Affinity Prediction on Neurosnap

Using AlphaBind Antibody-Antigen Affinity Prediction on Neurosnap could drastically accelerate pretrained or target-specific AlphaBind sequence-based antibody candidate ranking.

Flexible inference modes: Run the public pretrained checkpoint directly or supply measurements for target-specific adaptation.
Honest score semantics: Base-model and physical-KD jobs use log10 KD, while custom proxy scores remain on their original assay scale.
Reusable fine-tuned artifacts: Fine-tuned jobs return the resulting model and training metrics alongside ranked predictions.
No structure required: AlphaBind operates from antibody and antigen sequences, avoiding a separate complex-prediction step for early triage.

How to Use AlphaBind Antibody-Antigen Affinity Prediction on Neurosnap

To harness the capabilities of AlphaBind Antibody-Antigen Affinity Prediction, researchers can follow this streamlined workflow within Neurosnap:

Access Neurosnap: Start by logging in to the Neurosnap website.
Select Tool: From the list of available tools, choose AlphaBind Antibody-Antigen Affinity Prediction.
Provide Inputs: Provide all the inputs specified within the submission panel and optionally configure the tool as desired.
Run Tool: Submit the AlphaBind Antibody-Antigen Affinity Prediction job and Neurosnap will execute it in the cloud, automatically notifying you as soon as your results are ready.
Review Output: Explore your results through rich visualizations, including figures, plots, and interactive views designed to help you analyze findings with clarity and confidence.

Citations

Please cite the original work when using AlphaBind Antibody-Antigen Affinity Prediction in publications or research outputs.

Agarwal AA, Harrang J, Noble D, McGowan KL, Lange AW, Engelhart E, et al. AlphaBind, a domain-specific model to predict and optimize antibody-antigen binding affinity. mAbs. 2025;17(1):2534626. https://doi.org/10.1080/19420862.2025.2534626

Neurosnap Inc. (2022). Neurosnap: An online platform for computational biology and chemistry. Available at: https://neurosnap.ai/

Similar Services

Explore related tools that support similar research workflows:

BindFilter

ImaPEp Antibody-Antigen Binding Prediction

NeuroBind

ProteinMPNN-ddG

Proudly supporting 50,000+ scientists worldwide, including 7,000+ leading biotech and global biopharma organizations.